Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ECOR Stock Forecast 2026-2027
$9.11
Current Price
$75.57M
Market Cap
Buy 5
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ECOR Price Targets
+185.4%
To High Target of $26.00
+117.9%
To Median Target of $19.85
+31.7%
To Low Target of $12.00
ECOR Price Momentum
-4.3%
1 Week Change
+45.3%
1 Month Change
+74.5%
1 Year Change
+102.9%
Year-to-Date Change
-13.2%
From 52W High of $10.50
+119.0%
From 52W Low of $4.16
📊 TOP ANALYST CALLS
Did ECOR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if ElectroCore is one of their latest high-conviction picks.
Latest ECOR Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, ECOR has a bullish consensus with a median price target of $19.85 (ranging from $12.00 to $26.00). The overall analyst rating is Strong Buy (9.6/10). Currently trading at $9.11, the median forecast implies a 117.9% upside. This outlook is supported by 5 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ECOR Analyst Ratings
5
Buy
0
Hold
0
Sell
ECOR Price Target Range
Low
$12.00
Average
$19.85
High
$26.00
Current: $9.11
Latest ECOR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ECOR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 26, 2026 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $18.00 |
| Mar 13, 2025 | Ladenburg Thalmann | Buy | Maintains | $N/A | |
| Mar 13, 2025 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Dec 18, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Mar 14, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Jan 22, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Nov 9, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 10, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| May 4, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Apr 18, 2023 | CG Capital | Outperform | Reiterates | $N/A | |
| Apr 18, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Mar 9, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Jan 13, 2023 | Brookline Capital | Kemp Dolliver | Buy | Initiates | $1.25 |
| Jan 19, 2022 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $2.75 |
| Jul 27, 2021 | Ladenburg Thalmann | Buy | Initiates | $N/A | |
| Oct 23, 2020 | Brookline Capital | Buy | Initiates | $N/A | |
| Sep 30, 2020 | Maxim Group | Buy | Initiates | $N/A | |
| Aug 14, 2020 | BTIG | Buy | Upgrade | $N/A | |
| Aug 14, 2020 | HC Wainwright & Co. | Buy | Maintains | $3.00 | |
| Mar 24, 2020 | H.C. Wainwright | Buy | Reiterates | $N/A |
ElectroCore, Inc. (ECOR) Competitors
The following stocks are similar to ElectroCore based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ElectroCore, Inc. (ECOR) Financial Data
ElectroCore, Inc. has a market capitalization of $75.57M with a P/E ratio of -5.7x. The company generates $34.90M in trailing twelve-month revenue with a -44.1% profit margin.
Revenue growth is +42.6% quarter-over-quarter, while maintaining an operating margin of -55.5% and return on equity of +817.2%.
Valuation Metrics
Market Cap
$75.57M
Enterprise Value
$85.69M
P/E Ratio
-5.7x
PEG Ratio
-0.2x
Price/Sales
2.4x
Growth & Margins
Revenue Growth (YoY)
+42.6%
Gross Margin
+87.3%
Operating Margin
-55.5%
Net Margin
-44.1%
EPS Growth
+42.6%
Financial Health
Cash/Price Ratio
+11.7%
Current Ratio
1.0x
Debt/Equity
-1.7x
ROE
+817.2%
ROA
-58.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
ElectroCore, Inc. (ECOR) Business Model
About ElectroCore, Inc.
What They Do
Develops non-invasive vagus nerve stimulation devices.
Business Model
ElectroCore generates revenue primarily through the sale of its prescription device, gammaCore, which treats migraines and cluster headaches. Additionally, the company markets consumer wellness products like Truvaga and Truvaga Plus, which cater to personal health needs. The acquisition of NeuroMetrix has further diversified its offerings, allowing it to tap into the chronic pain and wellness markets.
Additional Information
Founded in 2005 and based in Rockaway, New Jersey, ElectroCore operates in the U.S., U.K., and internationally, focusing on neurology and pain management sectors. The company's commitment to drug-free therapies positions it as a key player in the bioelectronic medicine field.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
83
CEO
Mr. Daniel S. Goldberger
Country
United States
IPO Year
2018
Website
www.electrocore.comElectroCore, Inc. (ECOR) Latest News & Analysis
Latest News
Quick Summary
electroCore, Inc. (Nasdaq: ECOR) announced that a review article on non-invasive vagus nerve stimulation will be published in Frontiers in Neuroscience.
Why It Matters
The publication of electroCore’s research on non-invasive vagus nerve stimulation could enhance its credibility, attract investment, and potentially drive stock value through increased interest in its technology.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
electroCore, Inc. (Nasdaq: ECOR) will present at Planet MicroCap Las Vegas 2026, with Interim President and CFO Joshua Lev leading the presentation and one-on-one investor meetings.
Why It Matters
electroCore's presentation at a major investor conference signals potential for increased visibility and interest, which could influence stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
electroCore (NASDAQ: ECOR) is expanding its non-invasive vagus nerve stimulation platform into federal health care, commercial insurance, and consumer wellness markets, according to Interim President and CFO Joshua Lev.
Why It Matters
electroCore's expansion into federal health care, insurance, and wellness markets indicates potential revenue growth, making it a key player in the bioelectronic sector that investors may find attractive.
Source: MarketBeat
Market Sentiment:
Positive
Quick Summary
electroCore, Inc. (Nasdaq: ECOR) announced the publication of clinical findings in JAMA Network Open on transcutaneous electrical nerve stimulation for fibromyalgia pain relief.
Why It Matters
The publication in JAMA Network Open highlights electroCore's clinical advancements, potentially boosting credibility and investor confidence in its product efficacy and market prospects.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
electroCore, Inc. (ECOR) held its Q1 2026 earnings call, detailing financial performance and strategic updates. Further specifics on earnings and forecasts were discussed.
Why It Matters
The Q1 2026 earnings call for electroCore, Inc. provides insights into the company's financial performance and future outlook, influencing stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
electroCore reported Q1 2026 net sales of $9.6M, up 43% from Q1 2025. The company incurred a net loss of $5.3M, with Adjusted EBITDA loss improving to $2.3M. A conference call is scheduled for today at 4:30 PM EDT.
Why It Matters
ElectroCore's 43% sales growth indicates strong demand, while the reduced net loss suggests improved financial health, potentially attracting investor interest and influencing stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About ECOR Stock
What is ElectroCore, Inc.'s (ECOR) stock forecast for 2026?
Based on our analysis of 4 Wall Street analysts, ElectroCore, Inc. (ECOR) has a median price target of $19.85. The highest price target is $26.00 and the lowest is $12.00.
Is ECOR stock a good investment in 2026?
According to current analyst ratings, ECOR has 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $9.11. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ECOR stock?
Wall Street analysts predict ECOR stock could reach $19.85 in the next 12 months. This represents a 117.9% increase from the current price of $9.11. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is ElectroCore, Inc.'s business model?
ElectroCore generates revenue primarily through the sale of its prescription device, gammaCore, which treats migraines and cluster headaches. Additionally, the company markets consumer wellness products like Truvaga and Truvaga Plus, which cater to personal health needs. The acquisition of NeuroMetrix has further diversified its offerings, allowing it to tap into the chronic pain and wellness markets.
What is the highest forecasted price for ECOR ElectroCore, Inc.?
The highest price target for ECOR is $26.00 from at , which represents a 185.4% increase from the current price of $9.11.
What is the lowest forecasted price for ECOR ElectroCore, Inc.?
The lowest price target for ECOR is $12.00 from at , which represents a 31.7% increase from the current price of $9.11.
What is the overall ECOR consensus from analysts for ElectroCore, Inc.?
The overall analyst consensus for ECOR is bullish. Out of 4 Wall Street analysts, 5 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $19.85.
How accurate are ECOR stock price projections?
Stock price projections, including those for ElectroCore, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 16, 2026 4:56 AM UTC